as 07-26-2024 4:00pm EST
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
Upcoming Earnings Alert:
Get ready for potential market movements as Fresenius Medical Care AG FMS prepares to release earnings report on 30 Jul 2024.
Founded: | N/A | Country: | Germany |
Employees: | N/A | City: | N/A |
Market Cap: | 12.0B | IPO Year: | 1996 |
Target Price: | $24.00 | AVG Volume (30 days): | 232.9K |
Analyst Decision: | Hold | Number of Analysts: | 2 |
Dividend Yield: | Dividend Payout Frequency: | Annual | |
EPS: | 0.90 | EPS Growth: | -19.51 |
52 Week Low/High: | $16.37 - $26.52 | Next Earning Date: | 07-30-2024 |
Revenue: | $21,167,305,435 | Revenue Growth: | -0.41% |
Revenue Growth (this year): | 1.85% | Revenue Growth (next year): | 3.86% |
FMS Breaking Stock News: Dive into FMS Ticker-Specific Updates for Smart Investing
Zacks
11 hours ago
Simply Wall St.
16 days ago
Zacks
19 days ago
Zacks
25 days ago
Simply Wall St.
a month ago
MT Newswires
a month ago
PR Newswire
a month ago
Zacks
2 months ago
The information presented on this page, "FMS Fresenius Medical Care AG - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.